Stryker Stock Slides as Narrowed Full-Year Guidance Outweighs Earnings Beat

Shares of Stryker (NYSE: SYK) fell 8.4% in after-hours trading on Tuesday after the medical device company’s updated full-year guidance overshadowed a second-quarter earnings beat, signaling a more cautious outlook than investors had anticipated.

Guidance Trims Upside

The market's negative reaction was primarily driven by Stryker's revised forecast for the full year 2026. The company announced it was narrowing its expected range for key financial metrics:

• Organic net sales growth: Forecasted to be between 8.3% and 9.3%.
• Adjusted earnings per share (EPS): Expected to land between $14.95 and $15.10.

This updated guidance, while not a downgrade, effectively trimmed the higher end of potential outcomes, disappointing investors who had priced in a more robust recovery following operational disruptions earlier in the year.

Q2 Results Beat Expectations

Ad

Stryker's second-quarter performance was solid on its own. The company reported adjusted EPS of $3.69, which exceeded the Wall Street consensus estimate of $3.49. Revenue for the quarter came in at approximately $6.6 billion, an increase of 9.4% from the prior-year period and largely in line with analyst expectations.

However, the strong results were not enough to overcome the cautious full-year outlook. Investors had entered the earnings report with elevated hopes, particularly for a strong rebound after a cyberattack in March had weighed on the company's first-quarter results.

Market Context

The stock's decline reflects a classic "sell the news" scenario, where a company's financial results fail to meet heightened market expectations, even if they are positive. The stock had rallied significantly in the months leading up to the report, creating a high bar for the earnings release.

Following the announcement, shares were trading near $318.93, significantly below their 52-week high of $401.99. The market now appears to be recalibrating its expectations for Stryker's growth trajectory for the remainder of 2026.